{"name":"VentiRx Pharmaceuticals","permalink":"ventirx-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/ventirx-pharmaceuticals","homepage_url":"http://www.ventirx.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2006,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"corpinfo@ventirx.com","phone_number":"858-436-1530","description":"","created_at":"Wed Jan 13 03:21:45 UTC 2010","updated_at":"Thu Oct 04 02:49:09 UTC 2012","overview":"<p>VentiRx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of novel toll-like receptor 8 therapeutics for the treatment of cancer, respiratory, allergy, and autoimmune/inflammatory diseases. The company was founded in 2006 and is headquartered in San Diego, California with additional operations in Seattle.</p>","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/3107/73107v1-max-150x150.png"],[[220,88],"assets/images/resized/0007/3107/73107v1-max-250x250.png"],[[220,88],"assets/images/resized/0007/3107/73107v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Co-Founder ","person":{"first_name":"Michael","last_name":"J. Kamdar","permalink":"michael-j-kamdar","image":null}},{"is_past":false,"title":"Co-Founder ","person":{"first_name":"Robert","last_name":"M. Hershberg","permalink":"robert-m-hershberg","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$86.6M","funding_rounds":[{"round_code":"a","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100113e61d0002u&r=Rss&s=DJFVLS","source_description":"VentiRx Pharma Extends Series A To $51.6M  ","raised_amount":51600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":13,"investments":[{"company":null,"financial_org":{"name":"MedImmune Ventures","permalink":"medimmune-ventures","image":{"available_sizes":[[[150,34],"assets/images/resized/0004/9449/49449v1-max-150x150.jpg"],[[183,42],"assets/images/resized/0004/9449/49449v1-max-250x250.jpg"],[[183,42],"assets/images/resized/0004/9449/49449v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"ARCH Venture Partners","permalink":"arch-venture-partners","image":{"available_sizes":[[[131,71],"assets/images/resized/0003/6165/36165v1-max-150x150.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-250x250.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Frazier Healthcare Ventures","permalink":"frazier-healthcare-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/2779/32779v1-max-150x150.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-250x250.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020121003e8a3staa8&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121003e8a3staa8%26from%3dalert%26pid%3d32","source_description":" VentiRx Secures $35M from Celgene; VCs Get Possible Path to Liquidity ","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":3,"investments":[{"company":{"name":"Celgene","permalink":"celgene","image":{"available_sizes":[[[113,99],"assets/images/resized/0006/8834/68834v1-max-150x150.png"],[[113,99],"assets/images/resized/0006/8834/68834v1-max-250x250.png"],[[113,99],"assets/images/resized/0006/8834/68834v1-max-450x450.png"]],"attribution":null}},"financial_org":null,"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"12651 High Bluff Drive","address2":"Suite 200","zip_code":"92130","city":"San Diego","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,82],"assets/images/resized/0007/3106/73106v1-max-150x150.jpg"],[[250,137],"assets/images/resized/0007/3106/73106v1-max-250x250.jpg"],[[450,246],"assets/images/resized/0007/3106/73106v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}